PMO’s protective wrap: Unraveling its surfactant-mediated stabilization for next-generation antisense therapies
Authors:
Open Access
- 25 March 2026
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 37 (2) , 102897
Abstract
No abstract availableFunding Information
- Anusandhan National Research Foundation (SPR/2023/000358)
This publication has 8 references indexed in Scilit:
- Polysorbates’ effects on molecular and thermodynamic properties of phosphorodiamidate morpholino oligonucleotides’ structuresMolecular Therapy Nucleic Acids, 2026
- A Unified Phosphoramidite Platform for the Synthesis of Morpholino Oligonucleotides and Diverse Chimeric BackbonesJournal of the American Chemical Society, 2024
- Morpholino oligonucleotide-mediated exon skipping for DMD treatment: Past insights, present challenges and future perspectivesJournal of Biosciences, 2023
- Self-transfecting GMO-PMO chimera targeting Nanog enable gene silencing in vitro and suppresses tumor growth in 4T1 allografts in mouseMolecular Therapy Nucleic Acids, 2023
- Chemistry, structure and function of approved oligonucleotide therapeuticsNucleic Acids Research, 2023
- Therapeutic phosphorodiamidate morpholino oligonucleotides: Physical properties, solution structures, and folding thermodynamicsMolecular Therapy Nucleic Acids, 2023
- C5-pyrimidine-functionalized morpholino oligonucleotides exhibit differential binding affinity, target specificity and lipophilicityOrganic & Biomolecular Chemistry, 2022
- Guanidinium-Functionalized Flexible Azaproline Transporter for Efficient Intracellular Delivery of Proapoptotic Peptide and PDL1 Antisense Morpholino Oligo in Human Carcinoma Cells In VitroBioconjugate Chemistry, 2022